Skip to content

the effects of citalopram on brain waves of patients with major depressive disorder

Investigation the effects of Citalopram on the level of change in the alpha and theta brain waves of patient with major depressive disorder referred to Farshchian hospital, Hamadan

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203049202N1
Enrollment
30
Registered
2012-04-25
Start date
2012-04-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive dosorder. Mood [affective] disorders

Interventions

citalopram 20- 40 mg oral once in day for 2 months.
Treatment - Drugs
citalopram 20- 40 mg oral once in day for 2 months

Sponsors

Research Center For Behavioural Disorders And Substances Abuse Of Hamadan University Of Medical Scie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria:the patient doesn’t have another psychiatric diseases;the patient doesn’t have any medical problem;the patient doesn’t have history of epilepsy; the patient doesn’t percept another antidepressant drugs;the patient isn't postpartum depression;the patient doesn’t have treatment with ECT in three months ago;the patient doesn’t have any material or psychiatric drugs abuse in 1 year ago;the patient doesn’t have suicidal idea exclusion criteria:if patient is dead;if patient has any side effect of the drug;if patient don't like to continue

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Major depressive disorder. Timepoint: before intervention & 2 months after intervention. Method of measurement: hamilton depression rating scale.

Secondary

MeasureTime frame
Response to treatment. Timepoint: 2 months after intervention. Method of measurement: hamilton depression rating scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBoshra Rahimi

Hamadan University Of Medical Sciences

b.rahimi@umsha.ac.ir/rahimi.boshra@gmail.com+98 81 1827 4191

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026